a2 Milk Company stock analysis
Want to see NZ:ATM full AI Analyst Report?
a2 Milk Company (ATM) Stock Price & Analysis
ATM Stock Chart & Stats
- Day’s Range
- NZD 8.87 - NZD 9.12
- 52-Week Range
- NZD 6.25 - NZD 11.90
- Previous Close
- NZD 9.02
- Volume
- N/A
- Average Volume (3M)
- 259.78K
- Market Cap
- NZD 6.57B
- Enterprise Value
- NZD 5.94B
- Total Cash (Recent Filing)
- NZD 784.47M
- Total Debt (Recent Filing)
- NZD 24.31M
- Price to Earnings (P/E)
- 28.5
- Beta
- 0.89
- Next Earnings
- Feb 22, 2027 (Est.)
- EPS Estimate
- 0.13
- Last Dividend Ex-Date
- Sep 17, 2026
- Dividend Yield
- 7.03%
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet
Minimal leverage and substantial liquidity provide financial flexibility to fund growth, absorb operating volatility, and invest in supply-chain capacity without relying heavily on borrowing. This strengthens resilience and supports sustained capital allocation over the next several quarters.
Strong Profitability
Improving gross and net margins show that the branded A2 proposition can generate meaningful profit above commodity dairy economics. Healthy operating profitability should support reinvestment, protect earnings capacity, and provide a durable base for future growth.
Product And Geographic Growth
A broadening product pipeline and geographic expansion reduce reliance on a single category while creating additional routes to consumer adoption. Innovation-led growth can strengthen brand relevance, diversify revenue, and support longer-term scale across nutrition and dairy markets.
Bears Say
China IMF Disruption And Share Loss
The disruption damaged product availability and caused consumers to switch to alternative brands, creating a meaningful recovery challenge in an important market. Rebuilding distribution, consumer trust, and prior share may require sustained investment and execution over multiple quarters.
Weaker Cash Conversion
The sharp decline in operating and free cash flow means reported earnings converted into cash less effectively, reducing near-term funding capacity. Persistent working-capital demands, investment, or normalization costs could constrain internally funded growth despite the company’s strong balance sheet.
Margin Pressure And Recovery Phasing
Lower expected margins reflect weaker product mix, higher milk and ingredient costs, and elevated marketing reinvestment while recovery remains back-end weighted. This increases execution dependence and makes near-term earnings quality less predictable even if full-year revenue growth resumes.
a2 Milk Company News
ATM FAQ
What was a2 Milk Company’s price range in the past 12 months?
What is a2 Milk Company’s market cap?
When is a2 Milk Company’s upcoming earnings report date?
How were a2 Milk Company’s earnings last quarter?
Is a2 Milk Company overvalued?
Does a2 Milk Company pay dividends?
What is a2 Milk Company’s EPS estimate?
How many shares outstanding does a2 Milk Company have?
What happened to a2 Milk Company’s price movement after its last earnings report?
Which hedge fund is a major shareholder of a2 Milk Company?
What is the TipRanks Smart Score and how is it calculated?
Company Description
a2 Milk Company
The a2 Milk Company Limited, along with its affiliated entities, distributes A2 protein-branded dairy products and related merchandise across key international markets including Australia, New Zealand, China, various other Asian territories, and the United States. Its core offerings include fresh milk, marketed under the "a2 Milk" brand, and infant formula, sold as "a2 Platinum." This Auckland, New Zealand-headquartered company was founded in 2000 and officially changed its name from A2 Corporation Limited to its present form in April 2014.
- Sector
- Consumerdefensive
- Industry
- Packaged Foods
- CEO
- David L. Bortolussi
- Employees
- 485
- Website
- www.thea2milkcompany.com
- Address
- 51 Shortland Street, Auckland, AU, 1010, NZ
a2 Milk Company (ATM) Earnings & Revenues
ATM Company Deck
ATM Earnings Call
Earnings Call SentimentNeutral
The call presented a mixed picture: the company delivered strong top-line growth (+12.4%), solid underlying EBITDA and multiple growth vectors (U.S., ANZ, other nutritionals, innovation), completed strategic supply-chain moves (a2 Pokeno) and returned significant capital to shareholders. However, a material fourth-quarter supply-chain disruption severely impacted China label IMF sales and in-market availability, pressured reported margins and required elevated marketing and recovery spend. Management outlined a clear recovery plan and expects FY'27 growth weighted to the second half, but near-term margin and sales phasing remain challenged.
View all NZ:ATM earnings summariesATM Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 5 | 3 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 11 | 0 | 1 |










